| Literature DB >> 28624702 |
Anwen M Krause-Heuer1, Rheaclare Fraser-Spears2, Jeremy C Dobrowolski3, Mark E Ashford1, Naomi A Wyatt1, Maxine P Roberts1, Georgianna G Gould2, Wai-Ching Cheah1, Clarissa K L Ng1, Mohan Bhadbhade3, Bo Zhang4, Ivan Greguric1, Nial J Wheate5, Naresh Kumar3, Wouter Koek6, Paul D Callaghan1, Lynette C Daws7, Benjamin H Fraser8.
Abstract
Herein we describe the synthesis and evaluation of antidepressant properties of seven analogues (1-7) of the low affinity/high capacity transporter blocker decynium-22 (D-22). All analogues (1-7) were synthesized via base promoted coupling reactions between N-alkylated-2-methylquinolinium iodides or N-alkylated-4-methylquinolinium iodides and electrophilic N-alkylated-2-iodoquinolinium iodides. All final compounds were purified by re-crystallization or preparative HPLC and initial evaluation studies included; 1) screening for in vitro α1-adrenoceptor activity (a property that can lead to unwanted side-effects), 2) measuring antidepressant-like activity in a mouse tail suspension test (TST), and 3) measuring effects upon mouse locomotion. The results showed some analogues have lower affinities at α1-adrenoceptors compared to D-22 and showed antidepressant-like activity without the need for co-administration of SSRIs. Additionally, many analogues did not affect mouse locomotion to the same extent as D-22. Plans for additional evaluations of these promising analogues, including measurement of antidepressant-like activity with co-administration of selective serotonin re-uptake inhibitors (SSRIs), are outlined.Entities:
Keywords: Adrenoceptor; Antidepressant-like activity; Antidepressants; Decynium-22; Depression; SSRIs
Mesh:
Substances:
Year: 2017 PMID: 28624702 PMCID: PMC5564211 DOI: 10.1016/j.ejmech.2017.06.011
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514